
• Reported GAAP EPS of $1.13 down -5.04% YoY • Reported revenue of $982.87M up 10.77% YoY • Aptar currently expects adjusted earnings per share for the second quarter of 2026 to range from $1.32 to $1.40, assuming an effective tax rate of 22.5% to 24.5%.
Bullish
Aptar achieved 11% reported sales growth and returned $131 million to shareholders. This was supported by strong demand in Beauty, and robust growth in Pharma's injectables and consumer healthcare.
Bearish
Aptar experienced an 8% decrease in reported net income and margin compression across Pharma, Beauty, and Closures segments, with operational disruptions and unfavorable product mix impacting performance.